Co-Authors
This is a "connection" page, showing publications co-authored by VLAD SANDULACHE and JAN KEMNADE.
Connection Strength
2.783
-
Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Oral Oncol. 2023 10; 145:106536.
Score: 0.915
-
CD8 infiltration is associated with disease control and tobacco exposure in intermediate-risk oropharyngeal cancer. Sci Rep. 2020 01 14; 10(1):243.
Score: 0.715
-
Deployment of cisplatin in Veterans with oropharyngeal cancer: toxicity and impact on oncologic outcomes. Laryngoscope Investig Otolaryngol. 2023 Aug; 8(4):895-902.
Score: 0.228
-
Persistent ethnicity-associated disparity in anti-tumor effectiveness of immune checkpoint inhibitors despite equal access. Cancer Res Commun. 2022 07 26; 2022.
Score: 0.213
-
Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration. Mod Pathol. 2022 08; 35(8):1045-1054.
Score: 0.207
-
Consistent multimodality approach to oral cavity and high-risk oropharyngeal cancer in veterans. Am J Otolaryngol. 2021 Nov-Dec; 42(6):103166.
Score: 0.199
-
Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects. J Immunother Cancer. 2021 07; 9(7).
Score: 0.198
-
Multifactoral immune modulation potentiates durable remission in multiple models of aggressive malignancy. FASEB J. 2024 May 31; 38(10):e23644.
Score: 0.061
-
Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy. Head Neck. 2021 07; 43(7):1983-1994.
Score: 0.048